Cargando…
Predicting disease severity in metachromatic leukodystrophy using protein activity and a patient phenotype matrix
BACKGROUND: Metachromatic leukodystrophy (MLD) is a lysosomal storage disorder caused by mutations in the arylsulfatase A gene (ARSA) and categorized into three subtypes according to age of onset. The functional effect of most ARSA mutants remains unknown; better understanding of the genotype–phenot...
Autores principales: | Trinidad, Marena, Hong, Xinying, Froelich, Steven, Daiker, Jessica, Sacco, James, Nguyen, Hong Phuc, Campagna, Madelynn, Suhr, Dean, Suhr, Teryn, LeBowitz, Jonathan H., Gelb, Michael H., Clark, Wyatt T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360315/ https://www.ncbi.nlm.nih.gov/pubmed/37480112 http://dx.doi.org/10.1186/s13059-023-03001-z |
Ejemplares similares
-
Intrathecal baclofen in metachromatic leukodystrophy
por: van der Veldt, Nikki, et al.
Publicado: (2018) -
Developing therapeutic approaches for metachromatic leukodystrophy
por: Patil, Shilpa A, et al.
Publicado: (2013) -
Diffusion tensor imaging in metachromatic leukodystrophy
por: van Rappard, Diane F., et al.
Publicado: (2018) -
Metachromatic leukodystrophy and transplantation: remyelination, no cross‐correction
por: Wolf, Nicole I., et al.
Publicado: (2020) -
Acetobacter indonesiensis Bacteremia in Child with Metachromatic Leukodystrophy
por: Kohlmann, Rebekka, et al.
Publicado: (2016)